Abiopharma

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

New Form 8-K - MAIA Biotechnology, Inc. Filed: 2025-06-17 AccNo: 0001641172-25-015410 Size: 257 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form 8-K - RAPT Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0000950170-25-087359 Size: 166 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

New Form 4 - CytomX Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001610717-25-000235 Size: 8 KB

New Form 4 - Applied Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0000950170-25-087356 Size: 5 KB

New Form 4 - CytomX Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001610717-25-000234 Size: 9 KB

New Form 4 - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-06-17 AccNo: 0001104659-25-060254 Size: 6 KB

New Form 3 - Applied Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0000950170-25-087354 Size: 19 KB

New Form 4 - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-06-17 AccNo: 0001104659-25-060253 Size: 6 KB

New Form 8-K - Applied Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0000950170-25-087352 Size: 648 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - IOVANCE BIOTHERAPEUTICS, INC. Filed: 2025-06-17 AccNo: 0001104659-25-060251 Size: 6 KB

New Form 4 - Tarsus Pharmaceuticals, Inc. Filed: 2025-06-17 AccNo: 0001819790-25-000097 Size: 10 KB

Applied Therapeutics Announces Key Leadership Appointments

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC